|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
0.105 0.000 (0.000%) | 2024/06 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 1,089,037 | -16.036% | 1,297,036 | 1,273,572 | 1,185,168 | 1,510,126 |
| Cost of Sales | (909,152) | -16.067% | (1,083,190) | (1,069,410) | (1,028,264) | (1,321,626) |
| Gross Profit | 179,885 | -15.881% | 213,846 | 204,162 | 156,904 | 188,500 |
| 2024/06 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | (3,972) | -- | |
| Change in FV & Impairment on Others | (4,157) | -58.833% | (10,098) | (21,579) | (214,489) | (7,768) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 1,733 | -- | (20,959) | (1,625) | 3,220 | 10,880 | |
| Profit / (Loss) before Taxation | (2,792) | -97.509% | (112,105) | (188,013) | (670,804) | (492,226) | |
| Taxation | 3,372 | -43.706% | 5,990 | 0 | (5,203) | (1,245) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (167) | -- | 718 | 366 | 611 | 2,066 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 413 | -- | (105,397) | (187,647) | (675,396) | (491,405) | |
| 2024/06 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,607 | -- | (7,278) | (2,322) | 10,615 | (7,388) |
| Depreciation & Amortisation | 14,030 | -13.582% | 16,235 | 26,055 | 108,920 | 43,648 |
| Directors' Emoluments | 2,025 | -15.201% | 2,388 | 2,675 | 2,481 | 2,330 |
| 2024/06 - Final | %Chg (Compare to Final) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Final | %Chg (Compare to Final) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 0.060 | -- | -18.070 | -42.660 | -174.830 | -127.450 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.152) | -- | (0.031) | (0.096) | (0.279) | (1.059) |
| NBV per share ($) | 0.440 | -- | 0.471 | 0.734 | 1.488 | 3.220 |
| Remarks: | Real time quote last updated: 27/11/2024 10:05 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 413 |
| %Change | -- |
| EPS / (LPS) | RMB 0.001 |
| NBV Per Share (¥) | RMB 0.440 |